Atrion Corp logo

Atrion Corp

1
1
NAS:ATRI (USA)   Ordinary Shares
$ 475.83 +36.13 (+8.22%) 10:08 PM EST
44.76
P/B:
3.46
Market Cap:
$ 837.44M
Enterprise V:
$ 837.44M
Volume:
40.37K
Avg Vol (2M):
30.11K
Volume:
40.37K
Avg Vol (2M):
30.11K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Atrion Corp ( ) from 1990 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Atrion stock (ATRI) PE ratio as of May 15 2024 is 44.76. More Details

Atrion Corp (ATRI) PE Ratio (TTM) Chart

To

Atrion Corp (ATRI) PE Ratio (TTM) Historical Data

Total 1229
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Atrion PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-15 44.8 2024-03-12 39.4
2024-05-14 44.8 2024-03-11 39.5
2024-05-13 41.4 2024-03-08 40.0
2024-05-10 41.9 2024-03-07 37.6
2024-05-09 40.2 2024-03-06 35.8
2024-05-08 38.6 2024-03-05 37.3
2024-05-07 39.3 2024-03-04 35.3
2024-05-06 40.9 2024-03-01 32.6
2024-05-03 39.0 2024-02-29 32.9
2024-05-02 39.0 2024-02-28 32.9
2024-05-01 40.2 2024-02-27 31.9
2024-04-30 39.8 2024-02-26 32.1
2024-04-29 39.5 2024-02-23 31.8
2024-04-26 37.2 2024-02-22 30.9
2024-04-25 37.5 2024-02-21 32.9
2024-04-24 39.9 2024-02-20 32.3
2024-04-23 38.1 2024-02-16 32.0
2024-04-22 37.6 2024-02-15 32.1
2024-04-19 37.9 2024-02-14 30.5
2024-04-18 36.3 2024-02-13 31.0
2024-04-17 37.5 2024-02-12 35.3
2024-04-16 38.5 2024-02-09 34.4
2024-04-15 37.5 2024-02-08 33.4
2024-04-12 37.6 2024-02-07 33.4
2024-04-11 37.9 2024-02-06 31.6
2024-04-10 40.2 2024-02-05 30.2
2024-04-09 41.6 2024-02-02 30.7
2024-04-08 39.2 2024-02-01 30.9
2024-04-05 39.1 2024-01-31 30.9
2024-04-04 39.5 2024-01-30 30.4
2024-04-03 38.1 2024-01-29 30.4
2024-04-02 35.9 2024-01-26 29.4
2024-04-01 38.5 2024-01-25 29.4
2024-03-28 43.6 2024-01-24 30.0
2024-03-27 40.6 2024-01-23 30.3
2024-03-26 39.7 2024-01-22 30.2
2024-03-25 39.7 2024-01-19 30.5
2024-03-22 38.7 2024-01-18 30.1
2024-03-21 40.2 2024-01-17 28.0
2024-03-20 39.6 2024-01-16 30.4
2024-03-19 38.9 2024-01-12 31.9
2024-03-18 39.2 2024-01-11 32.2
2024-03-15 39.6 2024-01-10 31.3
2024-03-14 37.9 2024-01-09 32.3
2024-03-13 38.6 2024-01-08 34.6

Atrion Corp (ATRI) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Atrion Corp logo
Atrion Corp
NAICS : 339112 SIC : 3841
ISIN : US0499041053

Share Class Description:

ATRI: Ordinary Shares
Description
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.